CClinicalTrials.gg
CompletedNCT03285360Updated Jan 31, 2019

Effectiveness of Bioactiveglass Air Abrasion Versus Fluoride Varnish in Management of Dentin Hypersensitivity

A Phase 1 interventional study of Sylc and fluoride varnish (Bifluorid 10) in Hypersensitivity Dentin and Tooth Hypersensitivity, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-31.

Sponsored by Cairo University · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Will the use of Bioactive glass with air abrasion technology (Sylc) compared to Fluoride Varnish (Biflourid 10) affects the degree of pain in patients complaining from hypersensitivity due to non-carious lesions?

Read the detailed description
  • Population: Patients complaining from Dentin Hypersensitivity due to non-carious lesions.
  • Intervention: Sylc, Air Abrasion Bioactive glass (Denfotex Research Ltd.)
  • Comparison: BiFlourid 10, Fluoride Varnish (VOCO, Germany)
  • Outcome measures: Dentin Hypersensitivity

Outcome name Measuring device Measuring unit Dentin Hypersensitivity

  • Thermal
  • Tactile
  • Evaporative
02

Conditions studied

  • Hypersensitivity Dentin
  • Tooth Hypersensitivity

Keywords

  • Bifluoride, sylc, hypersensitivity,
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males or females.
  • Age: 18-70 years old.
  • Patients with good oral hygiene.
  • Co-operative patients who show interest to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with bad oral hygiene.
  • Patients with orthodontic appliances, or bridge work that might interfere with evaluation.
  • Patients who did any periodontal surgeries within the previous 6 months.
  • Patients who are allergic to any ingredients will be used in the study.
  • Pregnant and lactating women.
04

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    sylc bioactive glass

    Sylc is a dry powder (calcium sodium phosphosilicate), based on NovaMin powder. Bottle of small and coarse particles will be used for the treatment. Steps: 1. Isolation: D.M. will make proper isolation for the teeth using cotton rolls. 2. Hand piece: NSK Prophymate Neo will be used to deliver the powder particles on the sensitive areas. Air stream adjusted at 40-46 psi. 3. Application: The hand piece will be held at constant distance (3-4mm) away from the tooth surface, with 60-80 degrees on the buccal surfaces. The powder will be applied for 5-10 seconds per tooth in a circular movement. 4. Suction: High volume suction will be used on lingual side of the teeth to suck any particles, and avoid patient from swallowing it.

    Combination Product: Sylc

  • Active comparator
    fluoride varnish (Bifluorid 10)

    fluoride varnish Bifluorid 10(by VOCO) will be used. It is a rapid- drying suspension of equal amounts of sodium fluoride and calcium fluoride. The single dose form will be used, to make sure the amount of fluoride varnish used is standardized. Steps: 1. Preparation: The tooth will be properly cleaned, and the surface will be air-dried. 2. Dispensing: The foil will be pierced using a micro- tim, the opening will be enlarged, the brush will be wet in a circular movement. 3. Application: Thin coat will be applied on the tooth surface. The varnish will be left from 10-20 seconds then air dried. Concerning the storage of the Bifluoride 10, it will be stored in refrigerator at the operative clinic to avoid exposure to high temperature or sunlight.

    Combination Product: fluoride varnish (Bifluorid 10)

Interventions

  • Combination productSylc

    a dry powder (calcium sodium phosphosilicate), based on NovaMin powder. Bottle of small and coarse particles will be used for the treatment

    Also known as: Sylc bioactive glass

  • Combination productfluoride varnish (Bifluorid 10)

    It is a rapid- drying suspension of equal amounts of sodium fluoride and calcium fluoride.

    Also known as: Bifluorid 10

05

What researchers measure

Primary outcomes

  1. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 2 minutes after treatment

Secondary outcomes

  1. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 1 week

  2. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 2 weeks

  3. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 3 weeks

  4. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 4 weeks

  5. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 6 months

  6. Pain due to dentin hypersensitivity (evaporative stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by air blast measured by a 10 cm visual analogue scale VAS

    Time frame: 12 months

  7. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 2 minutes after treatment

  8. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 1 week

  9. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 2 weeks

  10. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 3 weeks

  11. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 4 weeks

  12. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 6 months

  13. Pain due to dentin hypersensitivity (tactile stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by tactile stimulation with a probe measured by a 10 cm visual analogue scale VAS

    Time frame: 12 months

  14. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 2 minutes after treatment

  15. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 1 week

  16. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 2 weeks

  17. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 3 weeks

  18. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 4 weeks

  19. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 6 months

  20. Pain due to dentin hypersensitivity (thermal stimulus)

    Pain arising from dentin hypersensitivity in non-carious lesions stimulated by cold water measured by a 10 cm visual analogue scale VAS

    Time frame: 12 months

06

Study locations

1 site
  • Faculty of dentistry
    Cairo, Cairo Governorate, Egypt
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03285360
Lead sponsor
Cairo University
Responsible party
Dina Ezz (Principal investigator, Cairo University) — Principal investigator
First posted
Sep 18, 2017
Start date
Oct 1, 2017
Primary completion
Dec 1, 2018
Completion
Jan 1, 2019
Last update
Jan 31, 2019

Study contacts

Dina E Mohamed, Master
principal investigator · Assistant lecturer, Conservative Dentistry Department, Faculty of Dentistry, Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion